Taiho Ventures LLC 4
4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
Taiho Ventures LLC
10% Owner
Transactions
- Purchase
Common Stock
2021-05-04$16.00/sh+312,500$5,000,000→ 2,068,909 total - Conversion
Series B Preferred Stock
2021-05-04−3,797,921→ 0 total→ Common Stock (438,098 underlying) - Conversion
Common Stock
2021-05-04+1,318,311→ 1,318,311 total - Conversion
Common Stock
2021-05-04+438,098→ 1,756,409 total - Conversion
Series A Preferred Stock
2021-05-04−11,428,570→ 0 total→ Common Stock (1,318,311 underlying)
Footnotes (2)
- [F1]On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.